Originalkatalog | Verfügbarkeit prüfen

CV8 THE COST-EFFECTIVENESS (COST-UTILITY) OF EPROSARTAN IN HYPERTENSIVE PATIENTS WITH CEREBROVASCULAR DISEASE IN BELGIUM, GERMANY, SPAIN, UNITED KINGDOM, AND SWEDEN

Schwander, B, Lindgren, P, Gradl, B
Veröffentlicht in: Value in Health ; volume 10, issue 6, page A237-A238 ; ISSN 1098-3015;
2007